Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer
GG5 PCaprostate cancer (PCa)nivolumabnivolumab-relatedHDRBTADTandrogen deprivation therapy
…d phase II trial, 31 patients with localized or oligometastatic GG5 PCa and >30% positive biopsy cores were evaluated between September…